...
ogn-img

Organon & Co, Common Stock

OGN

NYQ

$15.68

+$0.56

(3.7%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.88B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
2.9802
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.74M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
7.41%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.80
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.88 L
$22.7 H
$15.68

About Organon & Co, Common Stock

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameOGNSectorS&P500
1-Week Return2.08%-1.8%-0.77%
1-Month Return-2.55%-3.48%0.71%
3-Month Return-22.22%-7.2%8.81%
6-Month Return-22.61%-1.54%12.32%
1-Year Return39.63%8.39%30.57%
3-Year Return-45.69%6.07%29.21%
5-Year Return-52.84%44.07%91.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue7.78B8.10B6.30B6.17B6.26B[{"date":"2019-12-31","value":96.06,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":77.87,"profit":true},{"date":"2022-12-31","value":76.26,"profit":true},{"date":"2023-12-31","value":77.36,"profit":true}]
Cost of Revenue2.27B3.35B2.38B2.29B2.52B[{"date":"2019-12-31","value":67.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":71.17,"profit":true},{"date":"2022-12-31","value":68.54,"profit":true},{"date":"2023-12-31","value":75.14,"profit":true}]
Gross Profit5.50B4.75B3.92B3.88B3.75B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":86.3,"profit":true},{"date":"2021-12-31","value":71.27,"profit":true},{"date":"2022-12-31","value":70.51,"profit":true},{"date":"2023-12-31","value":68.11,"profit":true}]
Gross Margin70.76%58.66%62.21%62.84%59.84%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":82.9,"profit":true},{"date":"2021-12-31","value":87.92,"profit":true},{"date":"2022-12-31","value":88.81,"profit":true},{"date":"2023-12-31","value":84.57,"profit":true}]
Operating Expenses1.66B1.97B2.11B2.17B2.42B[{"date":"2019-12-31","value":68.69,"profit":true},{"date":"2020-12-31","value":81.37,"profit":true},{"date":"2021-12-31","value":87.2,"profit":true},{"date":"2022-12-31","value":89.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income3.85B2.85B1.62B1.48B1.33B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":74.06,"profit":true},{"date":"2021-12-31","value":42.08,"profit":true},{"date":"2022-12-31","value":38.42,"profit":true},{"date":"2023-12-31","value":34.49,"profit":true}]
Total Non-Operating Income/Expense(151.00M)(95.00M)(644.00M)(1.00B)(1.17B)[{"date":"2019-12-31","value":-15100000000,"profit":false},{"date":"2020-12-31","value":-9500000000,"profit":false},{"date":"2021-12-31","value":-64400000000,"profit":false},{"date":"2022-12-31","value":-100500000000,"profit":false},{"date":"2023-12-31","value":-117100000000,"profit":false}]
Pre-Tax Income3.70B2.68B1.53B1.12B673.00M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":72.51,"profit":true},{"date":"2021-12-31","value":41.37,"profit":true},{"date":"2022-12-31","value":30.36,"profit":true},{"date":"2023-12-31","value":18.21,"profit":true}]
Income Taxes390.00M520.00M178.00M205.00M(350.00M)[{"date":"2019-12-31","value":75,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":34.23,"profit":true},{"date":"2022-12-31","value":39.42,"profit":true},{"date":"2023-12-31","value":-67.31,"profit":false}]
Income After Taxes3.31B2.16B1.35B917.00M1.02B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":65.34,"profit":true},{"date":"2021-12-31","value":40.87,"profit":true},{"date":"2022-12-31","value":27.74,"profit":true},{"date":"2023-12-31","value":30.94,"profit":true}]
Income From Continuous Operations3.22B2.16B1.35B917.00M585.00M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.12,"profit":true},{"date":"2021-12-31","value":41.98,"profit":true},{"date":"2022-12-31","value":28.5,"profit":true},{"date":"2023-12-31","value":18.18,"profit":true}]
Income From Discontinued Operations(88.00M)(96.00M)---[{"date":"2019-12-31","value":-8800000000,"profit":false},{"date":"2020-12-31","value":-9600000000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income3.22B2.16B1.35B917.00M1.02B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.12,"profit":true},{"date":"2021-12-31","value":41.98,"profit":true},{"date":"2022-12-31","value":28.5,"profit":true},{"date":"2023-12-31","value":31.79,"profit":true}]
EPS (Diluted)--6.345.034.14[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.34,"profit":true},{"date":"2023-12-31","value":65.3,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

OGN
Cash Ratio 0.27
Current Ratio 1.70
Quick Ratio 1.21

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OGN
ROA (LTM) 7.91%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OGN
Debt Ratio Lower is generally better. Negative is bad. 0.96
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.04

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OGN
Trailing PE 2.99
Forward PE 5.03
P/S (TTM) 0.61
P/B 7.90
Price/FCF 60
EV/R 1.85
EV/Ebitda 7.62

FAQs

What is Organon & Co share price today?

Organon & Co (OGN) share price today is $15.68

Can Indians buy Organon & Co shares?

Yes, Indians can buy shares of Organon & Co (OGN) on Vested. To buy Organon & Co from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Organon & Co be purchased?

Yes, you can purchase fractional shares of Organon & Co (OGN) via the Vested app. You can start investing in Organon & Co (OGN) with a minimum investment of $1.

How to invest in Organon & Co shares from India?

You can invest in shares of Organon & Co (OGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in OGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Organon & Co shares
What is Organon & Co 52-week high and low stock price?

The 52-week high price of Organon & Co (OGN) is $22.7. The 52-week low price of Organon & Co (OGN) is $11.88.

What is Organon & Co price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Organon & Co (OGN) is 2.9802

What is Organon & Co price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Organon & Co (OGN) is 7.90

What is Organon & Co dividend yield?

The dividend yield of Organon & Co (OGN) is 7.41%

What is the Market Cap of Organon & Co?

The market capitalization of Organon & Co (OGN) is $3.88B

What is Organon & Co’s stock symbol?

The stock symbol (or ticker) of Organon & Co is OGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top